United States v. Brooks

33 F.4th 734
CourtCourt of Appeals for the Fifth Circuit
DecidedMay 9, 2022
Docket21-60633
StatusPublished

This text of 33 F.4th 734 (United States v. Brooks) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Brooks, 33 F.4th 734 (5th Cir. 2022).

Opinion

Case: 21-60633 Document: 00516311614 Page: 1 Date Filed: 05/09/2022

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

FILED May 9, 2022 No. 21-60633 Lyle W. Cayce Clerk

United States of America,

Plaintiff—Appellee,

versus

Davis Lamar Brooks,

Defendant—Appellant.

Appeal from the United States District Court for the Southern District of Mississippi USDC No. 3:11-CR-38-1

Before Willett, Engelhardt, and Wilson, Circuit Judges. Kurt D. Engelhardt, Circuit Judge: After being found not guilty of two firearms offenses by reason of insanity in 2013, Davis Lamar Brooks (“Brooks”) was placed on conditional release under 18 U.S.C. § 4243. In 2019 and again in 2020, Brooks moved to discontinue or modify his conditional release. For the reasons that follow, we AFFIRM the district court’s denial of Brooks’s requests. I. In 2011, a federal grand jury charged Brooks with two counts of possessing a firearm as a convicted felon. As his criminal case proceeded, it Case: 21-60633 Document: 00516311614 Page: 2 Date Filed: 05/09/2022

No. 21-60633

became apparent that Brooks was mentally unwell. Gripped by hallucinations and paranoia, Brooks professed, among other things, “that he had [a] microphone inserted in his ear by the Aryan Brotherhood, and indicated [that] he heard voices that were very bothersome to him.” Medical examiners diagnosed Brooks with paranoid schizophrenia. At a 2011 competency hearing, a federal magistrate found that Brooks may have been “suffering from a mental disease or defect rendering him mentally incompetent” and ordered authorities to monitor and treat Brooks accordingly. In hopes of restoring Brooks’s mental health and curbing the danger Brooks posed to others, the Bureau of Prisons (BOP) began administering antipsychotic medications to Brooks in 2012. Later that year, Brooks’s clinical psychologist increased Brooks’s dosage of Haldol—the antipsychotic drug deemed best for Brooks—from 75 milligrams to 100 milligrams and declared it “evident [that Brooks] was experiencing benefits [from] the medication.” 1 In June 2012, the Warden of the U.S. Medical Center for Federal Prisoners filed a certificate of Brooks’s competency with the district court. At a competency hearing two months later, the district court deemed Brooks competent to stand trial. Through counsel, Brooks promptly noticed his intent to rely on an insanity defense. The Government, through the BOP, largely accepted that

1 Of note here, Brooks’s dosage was eventually reduced to 50 milligrams and 25 milligrams, respectively. A February 2020 report by Brooks’s nurse practitioner, Natalie Moody, notes that Brooks’s Haldol dosage was decreased to 50 milligrams “per his request” at an April 2019 visit. In the same February 2020 report, Moody “lower[ed] the dose to 25 mg,” again at Brooks’s request. In ordering the latter reduction, Moody apparently took for granted Brooks’s “report[] [that] he feels he does not need the medications,” “den[ial] [of] depression, anxiety, or mood swings,” and “den[ial] [of] A/V hallucinations [and] any adverse effects.” In restoring Brooks’s 100-milligram dosage in the order at issue here, the district court took issue with Moody’s decision to reduce Brooks’s dosage at Brooks’s mere request.

2 Case: 21-60633 Document: 00516311614 Page: 3 Date Filed: 05/09/2022

Brooks was insane at the time of his alleged offenses. In a January 2013 report, the BOP acknowledged that Brooks had likely “suffered from a psychotic disorder for much of the past nine years” that significantly impaired his “capacity to appreciate the nature, quality, and wrongfulness of his actions.” With a general consensus as to Brooks’s insanity in place, the district court accepted stipulated facts at a bench trial and found Brooks not guilty by reason of insanity. The district court then committed Brooks to BOP custody under 18 U.S.C. § 4243 and ordered further psychological examination to determine Brooks’s propensity to harm persons or property upon conditional release. In August 2013, a BOP risk assessment found that the risk Brooks would pose to others on conditional release could be sufficiently mitigated by a diligent regimen of antipsychotic medications. After additional hearings and monitoring, the district court ordered that Brooks be “conditionally released in accordance with 18 U.S.C. § 4243(f),” which, as relevant here, provides for an insane defendant’s “conditional release under a prescribed regimen of medical, psychiatric, or psychological care or treatment.” In the same breath, the district court prescribed Brooks’s regimen of care and treatment— among other things, the court required Brooks to “continue to take such medication, including injectable units, as prescribed for him by [his] medical provider.” Several years of conditional release came and went without issue. Alas, in October 2018, Brooks’s probation officer filed a petition alleging multiple violations of Brooks’s terms of conditional release after Brooks was arrested for driving under the influence of alcohol. The petition specifically charged Brooks with violating release conditions requiring his compliance with state law and abstinence from alcohol, and, of particular relevance here, failing “to consistently comply with his mental health medication regiment [sic].”

3 Case: 21-60633 Document: 00516311614 Page: 4 Date Filed: 05/09/2022

While awaiting a revocation hearing, Brooks filed a motion for unconditional release. At the hearing, the district court found Brooks “guilty of violation” and determined that Brooks “shall remain on conditional release with [the] same medical regimen, with one [peripheral] clarification.” In August 2020, Brooks renewed his motion to “terminat[e] his conditional release and bring[] a final end to this case.” 2 The district court held a series of hearings to address Brooks’s motion. Receiving testimony from multiple witnesses, the district court diligently reviewed and considered the grounds for Brooks’s requests. At an August 13, 2021 hearing, the district court denied Brooks’s motion and gave a thorough explanation of its reasons for doing so. The district court also issued an order modifying Brooks’s conditions of release. As relevant here, the modified order required Brooks to “receive monthly injections of [Haldol]” at his previously prescribed dosage of 100 milligrams. Understandably, the district court observed that Brooks’s 100-milligram dosage had only been reduced because Brooks asked for it and articulated a desire for “a medical basis for [a dosage reduction], [as opposed to] a [mere] request from the defendant.” On appeal, Brooks takes issue with two aspects of the district court’s rulings. First, he contends that the district court erred by denying his motion for unconditional release. Second, he maintains that the district court erred by ordering his healthcare provider “to administer Haldol injections to [him] in the specific dosage amount of 100 milligrams,” a dosage he finds neither acceptable nor necessary. We address both arguments in turn and find both unavailing.

2 In the alternative, Brooks sought a modification of release conditions.

4 Case: 21-60633 Document: 00516311614 Page: 5 Date Filed: 05/09/2022

II. We begin with Brooks’s contention that the district court erred by denying his motion for unconditional release. The district court committed Brooks to conditional release under 18 U.S.C. §

Related

United States v. Wilson
Fifth Circuit, 2026

Cite This Page — Counsel Stack

Bluebook (online)
33 F.4th 734, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-brooks-ca5-2022.